ArticleEJHaem2024

Correction to "Changes in bone marrow fibrosis during momelotinib or ruxolitinib therapy do not correlate with efficacy outcomes in patients with myelofibrosis".

PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.